Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical model.
Ferreira AK, Cristofaro B, Menezes MC, de Oliveira AK, Tashima AK, de Melo RL, Silva CCF, Rodriguez MGP, Carvalho DCOS, de Azevedo RA, Junior PLS, Mambelli LI, Portaro FV, Pardanaud L, Eichmann A, Sant'Anna OA, Faria M.
Ferreira AK, et al. Among authors: portaro fv.
Oncotarget. 2020 Dec 22;11(51):4770-4787. doi: 10.18632/oncotarget.27839. eCollection 2020 Dec 22.
Oncotarget. 2020.
PMID: 33473260
Free PMC article.